PMID- 15063713 OWN - NLM STAT- MEDLINE DCOM- 20040512 LR - 20191210 IS - 0014-5793 (Print) IS - 0014-5793 (Linking) VI - 563 IP - 1-3 DP - 2004 Apr 9 TI - MDMA (Ecstasy) controls in concert a group of genes involved in GABA neurotransmission. PG - 3-6 AB - In several countries, 3,4-methylenedioxymethamphetamine (MDMA) is currently the most abundant psychoactive recreational drug. MDMA induces numerous neuropsychiatric behaviors, serotonergic neuron degeneration, programmed death of cultured cells, hyperthermia and occasional fatality. Using gene expression analysis in MDMA-treated mice, we identified changes in gamma-amino butyric acid (GABA) transporters and synaptotagmins I and IV. Additional experiments showed decreases in mRNAs encoding septin and dystrophin. Although belonging to different gene families, it is striking that these four protein groups are implicated in neurotransmission of GABA, a major inhibitory neurotransmitter involved in thermoregulation. MDMA may control these genes in a combined fashion, assigning GABA a pivotal role in MDMA activities. FAU - Simantov, Rabi AU - Simantov R AD - Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel. rabi.simantov@weizmann.ac.il FAU - Peng, Weiping AU - Peng W LA - eng PT - Journal Article PL - England TA - FEBS Lett JT - FEBS letters JID - 0155157 RN - 0 (Hallucinogens) RN - 0 (Illicit Drugs) RN - 0 (Nerve Tissue Proteins) RN - 0 (RNA, Messenger) RN - 0 (Serotonin Agents) RN - 56-12-2 (gamma-Aminobutyric Acid) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Animals MH - Gene Expression/*drug effects MH - Gene Expression Profiling MH - *Genes MH - Hallucinogens/pharmacology MH - Illicit Drugs/pharmacology MH - Mice MH - Models, Biological MH - N-Methyl-3,4-methylenedioxyamphetamine/*pharmacology MH - Nerve Tissue Proteins/drug effects MH - RNA, Messenger/drug effects MH - Serotonin Agents/*pharmacology MH - Synaptic Transmission/*drug effects MH - gamma-Aminobutyric Acid/*drug effects EDAT- 2004/04/06 05:00 MHDA- 2004/05/13 05:00 CRDT- 2004/04/06 05:00 PHST- 2004/02/16 00:00 [received] PHST- 2004/02/24 00:00 [revised] PHST- 2004/02/24 00:00 [accepted] PHST- 2004/04/06 05:00 [pubmed] PHST- 2004/05/13 05:00 [medline] PHST- 2004/04/06 05:00 [entrez] AID - S001457930400256X [pii] AID - 10.1016/S0014-5793(04)00256-X [doi] PST - ppublish SO - FEBS Lett. 2004 Apr 9;563(1-3):3-6. doi: 10.1016/S0014-5793(04)00256-X.